Pasithea Therapeutics
$0.5800
19
+$0.00+0% Friday 20:00
-$0.01-1.19%Friday 20:55After hours
Statistics
Day High
0.5848
Day Low
0.5848
52W High
2.06
52W Low
0.281
Volume
727
Avg. Volume
-
Mkt Cap
19.38M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
2DecExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.66
-0.48
-0.3
-0.12
Expected EPS
-0.21
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-20.43MNet Income
Analyst Ratings
3.00Average Price Target
The highest estimate is 3.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow KTTA. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Axsome Therapeutics
AXSM
Mkt Cap10.42B
BridgeBio Pharma
BBIO
Mkt Cap14.97B
Alkermes
ALKS
Mkt Cap7.95B
Acadia Pharmaceuticals
ACAD
Mkt Cap5.02B
Biogen
BIIB
Mkt Cap32.28B
AMGEN
AMGN
Mkt Cap233.78B
Jazz Pharmaceuticals
JAZZ
Mkt Cap15.87B
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Novartis
NVS
Mkt Cap292.35B
About
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.
Show more...
CEO
Tiago Reis Marques
Employees
5
Country
United States
ISIN
US70261F2020
Listings
0 Comments
Share your thoughts
FAQ
What is Pasithea Therapeutics stock price today?▼
The current price of KTTA is $0.58 USD — it has increased by +0% in the past 24 hours. Watch Pasithea Therapeutics stock price performance more closely on the chart.
What is Pasithea Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Pasithea Therapeutics stocks are traded under the ticker KTTA.
Is Pasithea Therapeutics stock price growing?▼
KTTA stock has risen by +3.57% compared to the previous week, the month change is a +28.89% rise, over the last year Pasithea Therapeutics has showed a -26.58% decrease.
What is Pasithea Therapeutics market cap?▼
Today Pasithea Therapeutics has the market capitalization of 19.38M
When is the next Pasithea Therapeutics earnings date?▼
Pasithea Therapeutics is going to release the next earnings report on December 02, 2026.
What is Pasithea Therapeutics revenue for the last year?▼
Pasithea Therapeutics revenue for the last year amounts to 0 USD.
What is Pasithea Therapeutics net income for the last year?▼
KTTA net income for the last year is -20.43M USD.
How many employees does Pasithea Therapeutics have?▼
As of September 05, 2026, the company has 5 employees.
In which sector is Pasithea Therapeutics located?▼
Pasithea Therapeutics operates in the Health & Wellness sector.
When did Pasithea Therapeutics complete a stock split?▼
The last stock split for Pasithea Therapeutics was on January 02, 2024 with a ratio of 1:20.
Where is Pasithea Therapeutics headquartered?▼
Pasithea Therapeutics is headquartered in MIAMI BEACH, United States.